Back to Agenda
Digital Transformation in EU Regulatory Space
Session Chair(s)
Zaide Frias, PHARMD
Head of Digital Business Transformation Task Force, European Medicines Agency, Netherlands
Rodrigo Palacios, MBA
Senior Director, Technical Regulatory Policy, F. Hoffmann-La Roche Ltd., Switzerland
Dive into the future of regulatory excellence with in this DIAmond session, on "Digital Transformation in the EU Regulatory Space." This session will focus on the concrete plans that have been made for digital transformation in the regulatory space for the next ten years and gathers Healthcare regulators, European Commission representatives, Patient advocates, Technology disruptors and Industry leaders to explore the critical success factors driving digital evolution. Join us and be part of the conversation that shapes the next era of regulatory dynamics. Don't miss your chance to navigate the transformative journey ahead.
See you at the forefront of regulatory innovation!
Speaker(s)
Lilia Luchianov, LLM, MBA
Policy Officer at DG Santé, European Commission, Belgium
Digital Transformation in the New General Pharmaceutical Legislation
Karl Broich, DrMed
President, Federal Institute for Drugs and Medical Devices (BfArM), Germany
NPAG, Network Developments, and Level Playing Field
Lorraine Nolan, PHD
Chief Executive, Health Products Regulatory Authority , Ireland
International Collaboration
Lars Bo Nielsen, MSC
Director General, Danish Medicines Agency (DKMA), Denmark
NCA perspective on Digital Transformation & AI
Álmath Spooner, PHD
Director of Regulatory Policy and Intelligence, AbbVie, Ireland
Medicine Innovation (Including RWE/RWD Future)
Andrew Warrington
Senior Industry Advisor in Health and Life Sciences, Microsoft, Switzerland
Jan Geissler, MBA
Managing Director, Patvocates, Germany
Patient Perspective
Have an account?